Rotenone Model of Parkinson Disease
暂无分享,去创建一个
Todd Sherer | T. Sherer | A. Panov | S. Dikalov | Natalia Shalbuyeva | J Timothy Greenamyre | Sergey Dikalov | Georgia M. Taylor | Georgia Taylor | Alexander Panov | Natalia Shalbuyeva | T. Greenamyre | J. Greenamyre
[1] D. Butterfield,et al. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia , 2005, Journal of the Neurological Sciences.
[2] F. H. van der Westhuizen,et al. Inhibition of complex I of the electron transport chain causes O2-. -mediated mitochondrial outgrowth. , 2005, American journal of physiology. Cell physiology.
[3] I. Reynolds,et al. Ca2+‐induced permeabilization promotes free radical release from rat brain mitochondria with partially inhibited complex I , 2005, Journal of neurochemistry.
[4] Ken-ichi Yoshida,et al. A Possible Site of Superoxide Generation in the Complex I Segment of Rat Heart Mitochondria , 2005, Journal of bioenergetics and biomembranes.
[5] Andreas Schober,et al. Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP , 2004, Cell and Tissue Research.
[6] Vladimir N. Uversky,et al. Neurotoxicant-induced animal models of Parkinson’s disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration , 2004, Cell and Tissue Research.
[7] Werner J. Schmidt,et al. Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain , 2004, Experimental Neurology.
[8] A. Panov,et al. Quantitative evaluation of the effects of mitochondrial permeability transition pore modifiers on accumulation of calcium phosphate: comparison of rat liver and brain mitochondria. , 2004, Archives of biochemistry and biophysics.
[9] Nicolas Lapointe,et al. Rotenone induces non‐specific central nervous system and systemic toxicity , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] G. Cecchini,et al. Function and structure of complex II of the respiratory chain. , 2003, Annual review of biochemistry.
[11] Todd B. Sherer,et al. Mechanism of Toxicity in Rotenone Models of Parkinson's Disease , 2003, The Journal of Neuroscience.
[12] A. Makrigiannakis,et al. Endometrial Pinopodes and Uterine Receptivity , 2003, Annals of the New York Academy of Sciences.
[13] D. Tweed,et al. Adaptations and Deficits in the Vestibulo‐Ocular Reflex after Peripheral Ocular Motor Palsies , 2003, Annals of the New York Academy of Sciences.
[14] D. Nicholls,et al. The Relationship between Free and Total Calcium Concentrations in the Matrix of Liver and Brain Mitochondria* , 2003, Journal of Biological Chemistry.
[15] Jean Féger,et al. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats , 2003, Journal of neurochemistry.
[16] Todd B. Sherer,et al. Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation , 2003, Experimental Neurology.
[17] A. Echaniz-Laguna,et al. Mitochondrial respiratory chain function in skeletal muscle of ALS patients , 2002, Annals of neurology.
[18] F. Forastiere,et al. Evaluation of risk of Parkinson's disease in a cohort of licensed pesticide users , 2002, Neurological Sciences.
[19] James R. Burke,et al. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines , 2002, Nature Neuroscience.
[20] R. Mason,et al. Noninvasive diagnostic tool for inflammation-induced oxidative stress using electron spin resonance spectroscopy and an extracellular cyclic hydroxylamine. , 2002, Archives of biochemistry and biophysics.
[21] T. Sherer,et al. Animal models of Parkinson's disease. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.
[22] T. Sherer,et al. Complex I and Parkinson's Disease , 2001, IUBMB life.
[23] S. Khuder,et al. Environmental risk factors and Parkinson's disease: a metaanalysis. , 2001, Environmental research.
[24] C. Palmeira,et al. Brain and liver mitochondria isolated from diabeticGoto‐Kakizaki rats show different susceptibility to induced oxidative stress , 2001, Diabetes/metabolism research and reviews.
[25] M. Beal,et al. Experimental models of Parkinson's disease , 2001, Nature Reviews Neuroscience.
[26] Todd B. Sherer,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.
[27] J. Klaunig,et al. Role of the mitochondrial membrane permeability transition (MPT) in rotenone-induced apoptosis in liver cells. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[28] Françoise Condé,et al. Replicating Huntington's disease phenotype in experimental animals , 1999, Progress in Neurobiology.
[29] I. Reynolds. Mitochondrial Membrane Potential and the Permeability Transition in Excitotoxicity , 1999, Annals of the New York Academy of Sciences.
[30] S. Chakraborti,et al. Oxidant, mitochondria and calcium: an overview. , 1999, Cellular signalling.
[31] M. Beal,et al. Mitochondrial dysfunction in neurodegenerative diseases. , 1998, Biochimica et biophysica acta.
[32] C. Fall,et al. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. , 1997, Biochimica et biophysica acta.
[33] H. Nishino,et al. Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: a speculative explanation , 1997, Neuroscience Research.
[34] A. Panov,et al. Mg2+ control of respiration in isolated rat liver mitochondria. , 1996, Biochemistry.
[35] M. Beal. Mitochondria, free radicals, and neurodegeneration , 1996, Current Opinion in Neurobiology.
[36] F. Sharp,et al. MK-801 reduces uptake and stimulates efflux of excitatory amino acids via membrane depolarization. , 1996, The American journal of physiology.
[37] J. Drapier,et al. Modulation of Iron Regulatory Protein Functions , 1996, The Journal of Biological Chemistry.
[38] J. Greene,et al. Exacerbation of NMDA, AMPA, and l‐Glutamate Excitotoxicity by the Succinate Dehydrogenase Inhibitor Malonate , 1995, Journal of neurochemistry.
[39] V. Massey. Activation of molecular oxygen by flavins and flavoproteins. , 1994, The Journal of biological chemistry.
[40] M. Crompton,et al. An ADP-sensitive cyclosporin-A-binding protein in rat liver mitochondria. , 1994, European journal of biochemistry.
[41] D. Flint,et al. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. , 1993, The Journal of biological chemistry.
[42] D. Higgins,et al. Quantitative Autoradiography of Dihydrorotenone Binding to Complex I of the Electron Transport Chain , 1992, Journal of neurochemistry.
[43] N. Sims. Rapid Isolation of Metabolically Active Mitochondria from Rat Brain and Subregions Using Percoll Density Gradient Centrifugation , 1990, Journal of neurochemistry.
[44] G. Radda,et al. Kinetic control of mitochondrial ATP synthesis. , 1986, Biochemistry.
[45] T. Ohnishi,et al. An analysis of some thermodynamic properties of iron-sulphur centres in site I of mitochondria. , 1980, The Biochemical journal.
[46] E. Cadenas,et al. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. , 1977, Archives of biochemistry and biophysics.
[47] P. Brookes,et al. Mitochondrial H(+) leak and ROS generation: an odd couple. , 2005, Free radical biology & medicine.
[48] F. Bricaire,et al. Neurodegenerative diseases and oxidative stress. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[49] P. Jenner,et al. Oxidative stress in Parkinson's disease , 2003, Annals of neurology.
[50] I. Fridovich,et al. Superoxide radical and superoxide dismutases. , 1995, Annual review of biochemistry.
[51] L. Ernster,et al. [87] Energy-coupling in nonphosphorylating submitochondrial particles , 1967 .